Johnson & Johnson
JNJFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Johnson & Johnson Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 19 annual periods. The latest annual period ends Dec 28, 2025. The latest insider filing shown is dated Jun 12, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| PINCUS CAPITAL MANAGEMENT, LP | 2026-03-31 | 7,649 | $1.87M | SEC filing |
| Rayburn West Financial Services LLC | 2026-03-31 | 3,924 | $959K | SEC filing |
| 25 LLC | 2026-03-31 | 1,164 | $285K | SEC filing |
| Hodges Capital Management Inc. | 2026-03-31 | 19,435 | $4.75M | SEC filing |
| Financial Enhancement Group LLC | 2026-03-31 | 1,262 | $296K | SEC filing |
| Abel Hall, LLC | 2026-03-31 | 10,067 | $2.46M | SEC filing |
| SUMITOMO LIFE INSURANCE CO | 2026-03-31 | 26,792 | $6.55M | SEC filing |
| Financial Partners Group, Inc | 2026-03-31 | 3,670 | $897K | SEC filing |
| LETSON INVESTMENT MANAGEMENT, INC. | 2026-03-31 | 78,977 | $19.3M | SEC filing |
| MATRIX ASSET ADVISORS INC/NY | 2026-03-31 | 1,622 | $396K | SEC filing |
| TRANSCEND CAPITAL ADVISORS, LLC | 2026-03-31 | 41,047 | $10M | SEC filing |
| Hibernia Wealth Partners, LLC | 2026-03-31 | 1,683 | $411K | SEC filing |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 2026-03-31 | 9,093 | $2.22M | SEC filing |
| Horizon Investments, LLC | 2026-03-31 | 248,327 | $60.7M | SEC filing |
| GREENWOOD GEARHART LLC | 2026-03-31 | 3,475 | $849K | SEC filing |
| Walter Public Investments Inc. | 2026-03-31 | 2,100 | $513K | SEC filing |
| FOSTER & MOTLEY INC | 2026-03-31 | 46,297 | Not shown | SEC filing |
| ARKANSAS FINANCIAL GROUP, INC. | 2026-03-31 | 1,564 | $377K | SEC filing |
| Harvest Portfolios Group Inc. | 2026-03-31 | 310,041 | $75.8M | SEC filing |
| AMALGAMATED BANK | 2026-03-31 | 444,574 | Not shown | SEC filing |
- Each value is checked against Johnson & Johnson's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 2 rows: the filed value is about 1,000 times too small for the share count at Johnson & Johnson's share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Johnson & Johnson's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-01-26 · Duato Joaquin: Larger than 18 of the 19 other insider sales of Common Stock on file. SEC filing
- 2025-09-04 · Taubert Jennifer L: Larger than all 19 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-11 | Wengel Kathryn E · EVP, Chief TO and Risk Officer | Common Stock | S — Open market or private sale | −10,000 | 241.15 | SEC filing |
| 2026-02-27 | Decker Robert J · VP Corporate Controller | Common Stock | S — Open market or private sale | −4,075 | 247.87 | SEC filing |
| 2026-02-20 | Schmid Timothy · EVP, WW Chair, MedTech | Common Stock | S — Open market or private sale | −1,322 | 245.66 | SEC filing |
| 2026-02-18 | Schmid Timothy · EVP, WW Chair, MedTech | Common Stock | S — Open market or private sale | −8,998 | 244.53 | SEC filing |
| 2026-02-18 | Schmid Timothy · EVP, WW Chair, MedTech | Common Stock | S — Open market or private sale | −13,625 | 244.20 | SEC filing |
| 2026-02-17 | Broadhurst Vanessa · EVP, Global Corp Affairs | Common Stock | S — Open market or private sale | −6,197 | 243.39 | SEC filing |
| 2026-02-17 | REED JOHN C · EVP, Innovative Medicine, R&D | Common Stock | S — Open market or private sale | −29,927 | 243.00 | SEC filing |
| 2026-02-17 | Swanson James D. · EVP, CIO | Common Stock | S — Open market or private sale | −20,521 | 242.70 | SEC filing |
Showing 8 of 11 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-11 | Wengel Kathryn E · EVP, Chief TO and Risk Officer | Employee Stock Options (Right to Buy) | M — Exercise or conversion of derivative security | −10,000 | SEC filing |
| 2026-06-11 | Wengel Kathryn E · EVP, Chief TO and Risk Officer | Common Stock | M — Exercise or conversion of derivative security | +10,000 | SEC filing |
| 2026-06-09 | HEWSON MARILLYN A · Director | Deferred Share Units | A — Grant, award, or other acquisition | +215 | SEC filing |
| 2026-06-09 | Pinto Daniel E · Director | Deferred Share Units | A — Grant, award, or other acquisition | +134 | SEC filing |
| 2026-06-09 | Woods Eugene A. · Director | Deferred Share Units | A — Grant, award, or other acquisition | +161 | SEC filing |
| 2026-05-01 | REED JOHN C · EVP, Innovative Medicine, R&D | Restricted Share Units | M — Exercise or conversion of derivative security | −25,255 | SEC filing |
| 2026-05-01 | REED JOHN C · EVP, Innovative Medicine, R&D | Common Stock | M — Exercise or conversion of derivative security | +25,255 | SEC filing |
| 2026-05-01 | REED JOHN C · EVP, Innovative Medicine, R&D | Common Stock | F — Payment of exercise price or tax by delivering securities | −11,002 | SEC filing |
Showing 8 of 30 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2023-08-23 | Johnson Paula A · Director | Common Stock | D — Disposition to the issuer | −11 | SEC filing |
Showing 1 of 1 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.